Australia markets closed

ImmuCell Corporation (ICCC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.0000+0.0900 (+1.83%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
No. of analysts0000
Avg. Estimate0000
Low estimate0000
High estimate0000
Year ago EPSN/A-0.11N/AN/A
Revenue estimateCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
No. of analysts1110
Avg. Estimate5.4M3.26M16.65MN/A
Low estimate5.4M3.26M16.65MN/A
High estimate5.4M3.26M16.65MN/A
Year ago salesN/A2.97M15.34M16.65M
Sales growth (year/est)N/A9.90%8.50%N/A
Earnings historyInvalid Date29/06/202029/09/202030/12/2020
Est. EPSN/A-0.1-0.08-0.04
Actual EPSN/A-0.11-0.040.03
DifferenceN/A-0.010.040.07
Surprise %N/A-10.00%50.00%175.00%
EPS trendCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
Current estimate0000
7 days ago0.05-0.08-0.110
30 days ago0.05-0.08-0.110
60 days ago0.05-0.08-0.110
90 days ago0.05-0.08-0.110
EPS revisionsCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesICCCIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current yearN/AN/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)53.90%N/AN/AN/A